Cite
HARVARD Citation
Deyell, R. et al. (2019). Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218. Pediatric blood & cancer. 66 (3), p. n/a. [Online].